What is the treatment for conjunctivitis (pink eye)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Conjunctivitis (Pink Eye)

Treatment depends on the underlying cause: bacterial conjunctivitis receives topical antibiotics (though mild cases are self-limited), viral conjunctivitis requires only supportive care, and allergic conjunctivitis responds to topical antihistamines with mast cell-stabilizing properties. 1

Bacterial Conjunctivitis

Mild Cases

  • Mild bacterial conjunctivitis often resolves spontaneously without treatment in immunocompetent adults 1
  • A 5-7 day course of broad-spectrum topical antibiotics is recommended by the American Academy of Ophthalmology, as it provides earlier clinical and microbiological remission (days 2-5) compared to placebo 1
  • Topical fluoroquinolones (moxifloxacin, levofloxacin, gatifloxacin, ciprofloxacin, besifloxacin) are effective against common pathogens including Staphylococcus aureus, Streptococcus pneumoniae, and Haemophilus influenzae 1
  • Alternative options include bacitracin ointment applied 1-3 times daily 2 or erythromycin ophthalmic ointment 3
  • Patients should return for evaluation if no improvement occurs after 3-4 days of treatment 4

Moderate to Severe Cases

  • Characterized by copious purulent discharge, pain, and marked inflammation 1
  • Obtain conjunctival cultures and Gram staining before initiating treatment 1
  • Treatment should be guided by laboratory results 1
  • Consider MRSA in patients from nursing homes or with community-acquired infections; compounded topical vancomycin may be needed for resistant cases 1

Special Bacterial Pathogens Requiring Systemic Treatment

  • Gonococcal conjunctivitis requires systemic antibiotics plus topical therapy, with daily monitoring until resolution 1, 4
  • Hospitalization may be necessary for severe cases and is mandatory for neonatal gonococcal conjunctivitis 4
  • Chlamydial conjunctivitis necessitates systemic antibiotic therapy, as more than 50% of infants have infection at other sites 1, 4
  • Sexual contacts of patients with sexually transmitted conjunctivitis should be treated concurrently 4
  • In resource-limited settings, povidone-iodine 1.25% ophthalmic solution can be used for chlamydial conjunctivitis 4

Viral Conjunctivitis

Adenoviral Conjunctivitis (Most Common)

  • No proven effective treatment exists for eradication of adenovirus infection 1
  • Symptomatic treatment includes artificial tears, cold compresses, and topical antihistamines 1, 5
  • Avoid antibiotics as they provide no benefit and may cause adverse effects 1, 5
  • Patients should minimize contact with others for 10-14 days from symptom onset in the last affected eye 5
  • Strict handwashing and disinfection of surfaces with sodium hypochlorite is essential, as adenovirus survives for weeks on surfaces 5

Severe Adenoviral Keratoconjunctivitis

  • Topical corticosteroids may be considered for severe cases with marked chemosis, lid swelling, epithelial sloughing, or membranous conjunctivitis, but require close monitoring 1, 5
  • Use corticosteroids with poor ocular penetration (fluorometholone, rimexolone, or loteprednol) to minimize risk of elevated intraocular pressure and cataract formation 6
  • Monitor intraocular pressure and pupils periodically during corticosteroid use 6
  • Taper slowly to the minimum effective dose 6, 5
  • For membranous conjunctivitis, debridement of membranes may prevent corneal epithelial abrasions or permanent cicatricial changes 5

Subepithelial Infiltrates (Late Complication)

  • Typically occur 1 or more weeks after onset of adenoviral conjunctivitis 6
  • Mild cases require only observation 6, 5
  • Cases with blurring, photophobia, and decreased vision may require topical corticosteroids at minimum effective dose 6, 5

Herpes Simplex Virus (HSV) Conjunctivitis

  • Topical ganciclovir 0.15% gel three to five times daily or trifluridine 1% solution five to eight times daily are recommended 6, 1
  • Oral antivirals (acyclovir 200-400 mg five times daily, valacyclovir 500 mg two or three times daily, or famciclovir 250 mg twice daily) are also effective 6, 1
  • Topical corticosteroids potentiate HSV infection and must be avoided 6, 1
  • Topical trifluridine causes epithelial toxicity if used for more than 2 weeks; topical ganciclovir is less toxic 6
  • Neonates require prompt consultation with pediatrician, as systemic HSV infection is life-threatening 6

Varicella Zoster Virus (VZV) Conjunctivitis

  • Topical antibiotics are recommended to prevent secondary bacterial infection, as vesicles undergo necrosis before healing 6, 5
  • Topical antivirals alone have not been shown to be helpful 6, 5
  • Oral antivirals (acyclovir 800 mg five times daily for 7 days, valacyclovir 1000 mg every 8 hours for 7 days, or famciclovir 500 mg three times daily for 7 days) are beneficial for persistent or recalcitrant disease 5
  • Use caution with oral antivirals in patients with impaired renal clearance 5

Molluscum Contagiosum-Related Conjunctivitis

  • Treatment requires removal of causative eyelid lesions through incision and curettage, simple excision, excision and cautery, or cryotherapy 5
  • Conjunctivitis may require weeks to resolve after lesion elimination 5

Allergic Conjunctivitis

First-Line Treatment

  • Topical antihistamines with mast cell-stabilizing properties are the treatment of choice 4
  • Simple measures include wearing sunglasses as barriers to airborne allergens, cold compresses, and refrigerated artificial tears 4
  • Identify and avoid triggering allergens 4

Persistent or Recurrent Cases

  • Mast cell stabilizers can be used for persistent or recurrent allergic conjunctivitis 4
  • For severe cases, a brief course (1-2 weeks) of topical corticosteroids with a low side-effect profile may be added 4
  • Monitor intraocular pressure if corticosteroids are used 1

Giant Papillary Conjunctivitis

  • Discontinue contact lens use in conjunction with topical anti-inflammatory agents 1
  • Baseline and periodic measurement of intraocular pressure if corticosteroids are used 1

Follow-Up Guidelines

  • Patients with severe disease (corneal epithelial ulceration or membranous conjunctivitis) should be re-evaluated within 1 week 6, 5
  • Patients not treated with corticosteroids should return if symptoms persist beyond 2-3 weeks 6, 5
  • Follow-up visits should include interval history, visual acuity measurement, and slit-lamp biomicroscopy 6, 5

Immediate Ophthalmology Referral Indications

Refer immediately for: 1, 4

  • Visual loss
  • Moderate or severe pain
  • Severe purulent discharge
  • Corneal involvement
  • Conjunctival scarring
  • Lack of response to therapy
  • Recurrent episodes
  • History of HSV eye disease
  • Immunocompromised state
  • Contact lens wearers with suspected bacterial conjunctivitis (to evaluate for corneal ulcers) 7

Critical Pitfalls to Avoid

  • Indiscriminate use of topical antibiotics or corticosteroids can induce toxicity and potentially prolong adenoviral infections and worsen HSV infections 4
  • Using topical corticosteroids in HSV conjunctivitis without antiviral coverage potentiates infection 1
  • Prolonged use of topical trifluridine (>2 weeks) causes epithelial toxicity 6, 1
  • Delayed referral for gonococcal conjunctivitis can lead to poor outcomes 1
  • Failure to consider sexual abuse in children with gonococcal or chlamydial conjunctivitis 1

Infection Control Measures

  • Do not share towels, pillows, or cosmetics 4
  • Contact lens wearers should suspend use until complete resolution 4
  • Frequent handwashing is essential 1
  • In clinical settings, consider abbreviated exams in dedicated rooms and disinfect exposed surfaces 5

References

Guideline

Conjunctivitis Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment of Conjunctivitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment of Viral Conjunctivitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.